RETA

Reata Pharmaceuticals, Inc. Class A Common Stock
RETA

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

RETA was delisted on the 25th of September, 2023.

Back to rankings

42 hedge funds and large institutions have $106M invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2016 Q2 according to their latest regulatory filings, with 42 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
42
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$66.5M
2
+$10.9M
3
+$4.8M
4
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
+$3.6M
5
EA
Emerald Advisers
Pennsylvania
+$3.31M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$66.5M
2
$10.9M
3
$4.8M
4
$3.6M
5
$3.31M
6
$2.96M
7
$2.9M
8
$1.25M
9
$1.09M
10
$1.06M
11
$1.02M
12
$991K
13
$946K
14
$893K
15
$677K
16
$433K
17
$372K
18
$327K
19
$236K
20
$224K
21
$217K
22
$198K
23
$177K
24
$146K
25
$139K
1
2